Radiant Sage receives Customer Value Enhancement Award from Frost & Sullivan

Monday, August 20, 2012 03:27 PM

Radiant Sage, a provider of on-demand clinical trial image management solutions based in Belmont, Mass., has received the Frost & Sullivan 2012 Customer Value Enhancement Award for its clinical trial image management solutions.

The award recognizes companies that have demonstrated excellence in implementing strategies and supporting products and services that proactively create value for their customers, with a focus on improving the return on investment that customers make in their products or services.

"We are honored to receive this prestigious award from Frost & Sullivan," said Venkatesan Thangaraj, CEO of Radiant Sage. "We have partnered with top global pharmaceutical companies to develop our clinical trial image management solutions to specifically meet their needs and the industry in general. This award validates our efforts to focus on the customer and the value we bring to their organization by simplifying the image management process for clinical trial sponsors and enabling them to quickly and cost-effectively develop drugs."

Jennifer Brice, global program manager of life sciences, Frost & Sullivan, said, "Radiant Sage's solutions were brought to the market specifically for clinical imaging trials. Its products and services enable its customers to take control over imaging trials in a seamless fashion. It is for these reasons that we presented Radiant Sage with this award."

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs